Bristol-Myers Squibb Company (BMY) Annual Income Statement (USD)
BMY Quarterly Financials (USD)
Frequently Asked Questions About Bristol-Myers Squibb Company (BMY) Stock
Bristol-Myers Squibb Company's (BMY) last reported annual revenue was USD 48.30 Billion.
Bristol-Myers Squibb Company's (BMY) annual revenue growth rate based on the revenue reported in the past 5 years is : 13.06%
Bristol-Myers Squibb Company's(BMY) is not profitable as of its last reported annual financials.
The net profit margin for Bristol-Myers Squibb Company's(BMY) from its laster reported year is -18.53%
The return on equity (ROE) for Bristol-Myers Squibb Company's(BMY) from its last reported annual financials is : -38.95%
The return on assets (ROA) for Bristol-Myers Squibb Company's(BMY) from its last reported annual financials is : 6.55%
The return on invested capital (ROIC) for Bristol-Myers Squibb Company's(BMY) from its last reported annual financials is : 41.68%
The Debt to Equity ratio for Bristol-Myers Squibb Company's(BMY) from its last reported annual financials is : 291.42%
The dividend yield for Bristol-Myers Squibb Company's(BMY) from its laster reported year is 4.20%
Bristol-Myers Squibb Company's(BMY) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BMY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
